What is the initial workup for hyponatremia?

Initial Hyponatremia Workup

When serum sodium falls below 131 mmol/L, immediately obtain serum osmolality, urine osmolality, urine sodium, urine electrolytes, and uric acid, while simultaneously assessing extracellular fluid (ECF) volume status through a combination of physical examination findings and invasive monitoring when available 1.

Algorithmic Diagnostic Approach

Step 1: Confirm True Hypotonic Hyponatremia

• Measure serum osmolality first to exclude pseudohyponatremia and translocational hyponatremia 2
• Normal or high serum osmolarity suggests laboratory error, hyperglycemia, or hypertriglyceridemia 1
• Only proceed with full workup if plasma osmolality is low (hypotonic hyponatremia)

Step 2: Essential Laboratory Tests

The minimum diagnostic workup must include 1:

• Serum osmolality
• Urine osmolality
• Urine sodium concentration
• Urine electrolytes
• Serum uric acid

Critical caveat: Do NOT routinely measure ADH or natriuretic peptide levels—these are not supported by evidence and add no diagnostic value 1.

Step 3: Determine Volume Status

Volume assessment is the key discriminator between cerebral salt wasting (CSW) and SIADH 1. Use multiple criteria:

Clinical examination findings:

• Skin turgor and mucous membranes
• Jugular venous pressure
• Presence of edema
• Orthostatic vital signs
• Daily weights
• Strict intake/output monitoring

Invasive monitoring when available:

• Central venous pressure via central line placement 1

Laboratory clues:

• Fractional uric acid excretion (newer parameter that may improve diagnostic accuracy) 3

Step 4: Categorize by Volume Status

Hypovolemic hyponatremia:

• Distinguish extrarenal losses (urine sodium <30 mmol/L) from intrarenal losses
• Intrarenal causes include CSW, diuretics, or adrenal insufficiency 1

Euvolemic hyponatremia:

• Rule out thyroid disease, hypocortisolism, and polydipsia BEFORE diagnosing SIADH 1
• SIADH is a diagnosis of exclusion

Hypervolemic hyponatremia:

• Less common in neurosurgical patients
• Consider cirrhosis, congestive heart failure, renal failure 1

Critical Pitfalls to Avoid

1. Don't delay treatment for complete workup in acute symptomatic cases: If severe symptoms (seizures, altered mental status, coma) are present, rapid correction takes precedence over diagnostic completion 4

2. Don't rely on ADH/natriuretic peptide levels: The evidence is conflicting and these tests don't change management 1

3. Don't misclassify volume status: This is the most common diagnostic error. The distinction between CSW and SIADH is critical because fluid restriction (appropriate for SIADH) can be catastrophic in CSW, particularly in subarachnoid hemorrhage patients where it increases cerebral infarction risk 1

4. Don't ignore the 131 mmol/L threshold: This is the trigger point for initiating full evaluation and treatment, not 135 mmol/L 1

Timing Considerations

Assess acuity immediately:

• Acute hyponatremia (<48 hours): More symptomatic, requires more aggressive management
• Chronic hyponatremia (>48 hours): Higher risk of osmotic demyelination with rapid correction 1

The rapidity of sodium decrease drives symptom severity and risk of poor outcomes more than the absolute sodium value 5, 6.

Special Populations

Neurosurgical patients (particularly subarachnoid hemorrhage): Even sodium levels of 131-135 mmol/L warrant treatment due to vasospasm risk 1. These patients require particularly careful volume status assessment as the CSW vs SIADH distinction directly impacts mortality.